サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1375076

アジア太平洋の医療用経皮吸収パッチ市場の2028年までの予測-地域別分析：タイプ、用途、流通チャネル別

Asia Pacific Transdermal Medical Patch Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and Distribution Channel

出版日
ページ情報
英文 158 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
アジア太平洋の医療用経皮吸収パッチ市場の2028年までの予測-地域別分析：タイプ、用途、流通チャネル別
出版日: 2023年08月21日
発行: The Insight Partners
ページ情報: 英文 158 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の医療用経皮吸収パッチ市場は、2023年の21億2,631万米ドルから2028年には27億4,432万米ドルに成長すると予測されています。2023年から2028年までのCAGRは5.2%と推定されます。

スマートパッチと三次元（3D）印刷パッチの進歩がアジア太平洋医療用経皮吸収パッチ市場を後押し

経皮薬物投与ルートは新規性があり、持続的ドラッグデリバリーの信頼できる手段の一つです。この分野で重要な研究が行われ、この形態のドラッグデリバリーに対する研究者の関心が高まっていることから、マーケットプレースに出回る経皮パッチの数は急増すると予想されます。経皮パッチは数十年前から注目されており、ニコチン、フェンタニル、ニトログリセリン、クロニジンなどの薬物を送達し、さまざまな疾患や症状を治療するために使用されてきました。

2022年に発表された「A smart hydrogel patch with high transparency, adhesiveness, and hemostasis for all-round treatment and glucose monitoring of diabetic foot ulcers」と題された研究によると、科学者たちは糖尿病性足潰瘍をモニターし治療するためのインテリジェントなパッチを開発しました。このシステムは、超高透明ポリマー・ネットワークを持つ導電性ハイドロゲル・パッチから作製されます。

調査チームは、3Dプリンティング技術を利用して、患者のニーズに合わせてカスタマイズした経皮パッチ（例えば、創傷治癒のための3Dプリントパッチ）を作製しています。2022年に発表されたJangらによる「Gelatin Methacrylate Hydrogel for Tissue Engineering Applications-A Review on Material Modifications（組織工学応用のためのゼラチン・メタクリレート・ハイドロゲル-材料改変に関する総説）」と題する研究では、ゼラチン・メタクリル酸塩（GelMA）が、調整可能な物理的特性を持つ実行可能な選択肢として試験されました。血管内皮増殖因子（VEGF）を模倣したペプチドを組み込んだGelMAハイドロゲルは、ハイドロゲルインクのせん断減粘特性により、3Dバイオプリンターを使って印刷することに成功しました。ハイドロゲルパッチの3D構造は高い多孔性と吸水性を有していました。ハイドロゲル・パッチからゆっくりと放出されるVEGFペプチドは、細胞生存率、増殖、管状構造形成を促進することができ、3D Gel-MA-VEGFハイドロゲル・パッチが創傷被覆に使用できることを示しています。

この研究では、2種類の液体モノマー-ポリエチレングリコールジアクリレート（PEGDA）とビニルピロリドン（VP）-を異なる割合で用いて、最終ポリマーの機械的強度、重合速度、膨潤速度を改善しました。樹脂への最適な薬物負荷により、AHP-3は製造工程を通して安定であり、最終ポリマーの物性に影響を及ぼさないことが示されました。3Dスキャンした顔モデルを用いて、パーソナライズされたパッチがコンピュータ支援設計ソフトウェアで設計され、デジタル光加工3Dプリンターを用いて最適化された樹脂で作製されました。作製された経皮パッチのin vitro特性評価では、ヒト死体皮膚への浸透能力が示され、圧縮後も無傷でした。

アジア太平洋の医療用経皮吸収パッチ市場概要

アジア太平洋地域の医療用経皮吸収パッチ市場は、オーストラリア、中国、インド、日本、韓国、その他アジア太平洋地域に区分されます。この地域の成長の背景には、がんや遺伝子変異に関する研究の拡大、疾患モデリングの増加、医療用経皮吸収パッチを提供する市場開拓があります。ヘルスケア施設の発展、幹細胞技術に関連する重要な事実を共有する高齢化人口の増加、海外事業体とのパートナーシップの増加などの主な発展要因は、予測期間中の市場成長をさらに促進すると思われます。

アジア太平洋の医療用経皮吸収パッチ市場の収益と2028年までの予測（金額）

アジア太平洋の医療用経皮吸収パッチ市場のセグメンテーション

アジア太平洋の医療用経皮吸収パッチ市場は、タイプ、用途、流通チャネル、国に区分されます。

タイプ別では、アジア太平洋の医療用経皮吸収パッチ市場は、単層薬剤接着剤、多層薬剤接着剤、リザーバー、蒸気パッチ、マトリックスに区分されます。2023年のアジア太平洋の医療用経皮吸収パッチ市場では、マトリックスセグメントが最大の市場シェアを記録しました。

用途別では、アジア太平洋の医療用経皮吸収パッチ市場は、神経疾患、疼痛管理、ニコチン禁煙、心血管障害、ホルモン療法、その他に区分されます。2023年には疼痛管理分野が最大の市場シェアを占めています。

アジア太平洋の医療用経皮吸収パッチ市場は、流通チャネル別に病院薬局、小売薬局、オンライン薬局に区分されます。病院薬局セグメントが2023年に最大の市場シェアを占めました。

国別に見ると、アジア太平洋地域の医療用経皮吸収パッチ市場は、オーストラリア、中国、インド、日本、韓国、その他アジア太平洋地域に区分されます。2022年の市場シェアは日本が独占。

Boehringer Ingelheim International GmbH、Endo International Inc、久光製薬株式会社、Johnsons and Johnsons、Medline Industries LP、Novartis AG、Teva Pharmaceutical Industries Ltd.、Viatris Inc.が、この地域の医療用経皮吸収パッチ市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 医療用経皮吸収パッチ市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の医療用経皮吸収パッチ市場- 市場情勢

  • 概観
  • PEST分析
    • アジア太平洋のPEST分析
  • 専門家の見解

第5章 アジア太平洋の医療用経皮吸収パッチ市場：主要市場力学

  • 市場促進要因
    • 慢性疾患の有病率の増加
    • タバコ消費の増加
  • 市場抑制要因
    • 薬剤の不具合による医療用経皮吸収パッチのリコール
  • 市場機会
    • 戦略的イニシアチブの増加
  • 今後の動向
    • スマートパッチと3Dプリントパッチの進歩
  • インパクト分析

第6章 アジア太平洋の医療用経皮吸収パッチ市場の分析

  • アジア太平洋の医療用経皮吸収パッチ市場の収益と予測分析

第7章 アジア太平洋の医療用経皮吸収パッチ市場-タイプ別収益と2028年までの予測

  • 医療用経皮吸収パッチ市場のタイプ別収益シェア（2022年、2028年）
  • 単層型薬物接着剤
  • 多層薬物接着剤
  • リザーバー
  • 蒸気パッチ
  • マトリックス

第8章 アジア太平洋の医療用経皮吸収パッチ市場：用途別収益と2028年までの予測

  • 医療用経皮吸収パッチ市場の用途別売上高シェア（2022年、2028年）
  • 神経疾患
  • 疼痛管理
  • ニコチン停止
  • 心血管疾患
  • ホルモン療法
  • その他

第9章 アジア太平洋の医療用経皮吸収パッチ市場-2028年に至る収益と予測- 販売チャネル別

  • 医療用経皮吸収パッチ市場の流通チャネル別収益シェア（2022年および2028年）
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 医療用経皮吸収パッチ市場：2028年までの収益と予測：国別分析

  • アジア太平洋

第11章 業界情勢

  • 成長戦略

第12章 企業プロファイル

  • Hisamitsu Pharmaceutical Co Inc
  • Medline Industries LP
  • Johnson & Johnson
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc
  • Endo Pharmaceuticals Inc
  • Boehringer Ingelheim International GmbH

第13章 付録

図表

List Of Tables

  • Table 1. China Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. China Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 3. China Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Japan Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Japan Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Japan Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. India Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. India Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. India Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. South Korea Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. South Korea Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 12. South Korea Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Australia Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Australia Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Australia Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Rest of Asia-Pacific Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Rest of Asia-Pacific Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of Asia-Pacific Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Recent Growth Strategies in Transdermal Medical Patch Market
  • Table 20. Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Transdermal Medical Patch Market Segmentation
  • Figure 2. Asia Pacific Transdermal Medical Patch Market by Region
  • Figure 3. Asia Pacific Transdermal Medical Patch Market Overview
  • Figure 4. Matrix is The Largest Share of Type Segment in Asia Pacific Transdermal Medical Patch Market
  • Figure 5. Japan Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Asia Pacific: PEST Analysis
  • Figure 7. Asia Pacific Experts' Opinion
  • Figure 8. Transdermal Medical Patch Market Impact Analysis of Drivers and Restraints
  • Figure 9. Asia Pacific Transdermal Medical Patch Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Asia Pacific Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
  • Figure 11. Single-Layer Drug In-Adhesive: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Multi-Layer Drug In-Adhesive: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Reservoir: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Vapor Patch: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Matrix: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Asia Pacific Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
  • Figure 17. Neurologic Conditions: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Pain Management: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Nicotine Cessation: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Cardiovascular Disorders: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Hormonal Therapy: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Others: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Asia Pacific Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022 and 2028)
  • Figure 24. Hospital Pharmacies: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Retail Pharmacies: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Online Pharmacies: Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Asia-Pacific: Transdermal Medical Patch Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 28. Asia-Pacific: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
  • Figure 29. China: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Japan: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. India: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. South Korea: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Australia: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Rest of Asia-Pacific: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00028751

The Asia Pacific transdermal medical patch market is expected to grow from US$ 2,126.31 million in 2023 to US$ 2,744.32 million by 2028. It is estimated to register a CAGR of 5.2% from 2023 to 2028.

Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches Fuel Asia Pacific Transdermal Medical Patch Market

The transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being carried out in this field and increasing interest of researchers in this form of drug delivery, the number of transdermal patches reaching the marketplace is expected to rise sharply. Transdermal patches have attracted attention for decades and were used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various diseases or conditions.

According to a study titled "A smart hydrogel patch with high transparency, adhesiveness, and hemostasis for all-round treatment and glucose monitoring of diabetic foot ulcers," published in 2022, scientists have developed an intelligent patch to monitor and treat diabetic foot ulcers. This system is fabricated from conductive hydrogel patches with an ultra-high transparency polymer network.

Researchers are using 3D printing technology to create customized transdermal patches (e.g., a 3D-printed patch for wound healing) tailored as per patient's needs. In a study by Jang et al. titled "Gelatin Methacrylate Hydrogel for Tissue Engineering Applications-A Review on Material Modifications," published in 2022, gelatin methacrylate (GelMA) was tested as a viable option with tunable physical properties. GelMA hydrogel incorporating a vascular endothelial growth factor (VEGF)-mimicking peptide was successfully printed using a 3D bio-printer due to the hydrogel inks' shear-thinning properties. The 3D structure of the hydrogel patch had high porosity and water absorption properties. Slowly released from hydrogel patches, VEGF peptide can promote cell viability, proliferation, and tubular structure formation, indicating that the 3D Gel-MA-VEGF hydrogel patch can be used for wound dressing.

In this study, two liquid monomers-polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)-in different proportions were used to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software and fabricated in optimized resin using a digital light processing 3D printer. In vitro characterization of the prepared transdermal patches showed their ability to penetrate human cadaver skin, and they remained intact after compression.

Asia Pacific Transdermal Medical Patch Market Overview

The transdermal medical patch market in Asia Pacific is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The regional growth is attributed to growing research on cancer and gene mutations, increasing disease modeling, and developments by market players offering transdermal medical patch. Factors such as developing healthcare facilities, growing aging population to share key facts associated with stem cell technologies, and increasing partnerships with foreign entities are likely to further propel the market growth during the forecast period.

Asia Pacific Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Transdermal Medical Patch Market Segmentation

The Asia Pacific transdermal medical patch market is segmented into type, application, distribution channel, and country.

Based on type, the Asia Pacific transdermal medical patch market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch, and matrix. The matrix segment registered the largest market share in Asia Pacific transdermal medical patch market in 2023.

Based on application, the Asia Pacific transdermal medical patch market is segmented into neurologic conditions, pain management, nicotine cessation, cardiovascular disorders, hormonal therapy, and others. The pain management segment held the largest market share in 2023.

Based on distribution channel, the Asia Pacific transdermal medical patch market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2023.

Based on country, the Asia Pacific transdermal medical patch market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. Japan dominated the market share in 2022.

Boehringer Ingelheim International GmbH, Endo International Inc, Hisamitsu Pharmaceutical Co Inc, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., and Viatris Inc are the leading companies operating in the transdermal medical patch market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific transdermal medical patch market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific transdermal medical patch market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving transdermal medical patch market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Transdermal Medical Patch Market - by Type
    • 1.3.2 Asia Pacific Transdermal Medical Patch Market - by Application
    • 1.3.3 Asia Pacific Transdermal Medical Patch Market - by Distribution Channel
    • 1.3.4 Asia Pacific Transdermal Medical Patch Market - by Country

2. Transdermal Medical Patch Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Transdermal Medical Patch Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Asia Pacific PEST Analysis
  • 4.3 Expert's Opinion

5. Asia Pacific Transdermal Medical Patch Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Growing Consumption of Tobacco
  • 5.2 Market Restraints
    • 5.2.1 Recalls of Transdermal Medical Patches due to Drug Failure
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Strategic Initiatives
  • 5.4 Future Trends
    • 5.4.1 Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches
  • 5.5 Impact analysis

6. Transdermal Medical Patch Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Transdermal Medical Patch Market Revenue Forecast and Analysis

7. Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Type

  • 7.1 Overview
  • 7.2 Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
  • 7.3 Single-Layer Drug In-Adhesive
    • 7.3.1 Overview
    • 7.3.2 Single-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Multi-Layer Drug In-Adhesive
    • 7.4.1 Overview
    • 7.4.2 Multi-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Reservoir
    • 7.5.1 Overview
    • 7.5.2 Reservoir: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Vapor Patch
    • 7.6.1 Overview
    • 7.6.2 Vapor Patch: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Matrix
    • 7.7.1 Overview
    • 7.7.2 Matrix: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Application

  • 8.1 Overview
  • 8.2 Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
  • 8.3 Neurologic Conditions
    • 8.3.1 Overview
    • 8.3.2 Neurologic Conditions: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Pain Management
    • 8.4.1 Overview
    • 8.4.2 Pain Management: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Nicotine Cessation
    • 8.5.1 Overview
    • 8.5.2 Nicotine Cessation: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Cardiovascular Disorders
    • 8.6.1 Overview
    • 8.6.2 Cardiovascular Disorders: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Hormonal Therapy
    • 8.7.1 Overview
    • 8.7.2 Hormonal Therapy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Distribution Channels

  • 9.1 Overview
  • 9.2 Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022and 2028)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Retail Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Retail Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Online Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

10. Transdermal Medical Patch Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Asia-Pacific: Transdermal Medical Patch Market
    • 10.1.1 Overview
    • 10.1.2 Asia-Pacific: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
      • 10.1.2.1 China: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.3 China: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.1.4 China: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.1.5 China: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.2 Japan: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.3 Japan: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.2.4 Japan: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.2.5 Japan: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.3 India: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.3 India: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.3.4 India: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.3.5 India: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.4 South Korea: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 South Korea: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.3 South Korea: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.4.4 South Korea: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.4.5 South Korea: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.5 Australia: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 Australia: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.5.3 Australia: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.5.4 Australia: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.5.5 Australia: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.6 Rest of Asia-Pacific: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia-Pacific: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.6.3 Rest of Asia-Pacific: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.6.4 Rest of Asia-Pacific: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.6.5 Rest of Asia-Pacific: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Hisamitsu Pharmaceutical Co Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medline Industries LP
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Johnson & Johnson
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Novartis AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Teva Pharmaceutical Industries Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Viatris Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Endo Pharmaceuticals Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Boehringer Ingelheim International GmbH
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms